Literature DB >> 12466362

Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions.

Lone Frydelund-Larsen1, Csilla Krausz, Henrik Leffers, Anna Maria Andersson, Elisabeth Carlsen, Susanne Bangsboell, Ken McElreavey, Niels E Skakkebaek, Ewa Rajpert-De Meyts.   

Abstract

Testicular production of inhibin B is believed to be dependent on the presence of germ cells within the seminiferous tubules. However, this association has recently been questioned in patients with deletions of azoospermia factor (AZF) on the Y chromosome. We have addressed this problem in 442 unselected infertile/subfertile patients (excluding obstructive and iatrogenic forms) who were analyzed for Yq microdeletions. AZFc microdeletions were found in 16 patients (3.8% of the total infertile group, but 9% of the subgroup with azoospermia or severe oligozoospermia with sperm concentration <1 x 10(6)/ml). The reproductive hormone profiles in patients with AZFc microdeletions were analyzed and compared with those in infertile patients without microdeletions and those in fertile control individuals. The mean serum inhibin B concentration in the patients with AZFc microdeletions (39.5 +/- 36.0 pg/ml) was significantly lower than that in the group of infertile patients without microdeletions (134.6 +/- 88.5 pg/ml). However, no significant difference was found compared with that in a matched group of infertile patients with comparably low sperm counts (72.6 +/- 75.5 pg/ml). Bilateral testicular biopsies in the AZFc-deleted patients revealed a variable histological pattern suggestive of a progressive depletion of seminiferous epithelium. An association between testicular pathology and the reproductive hormone profile was found; the more severe forms had lower inhibin B and higher FSH levels. Importantly, if Sertoli cell-only tubules were prevalent in the biopsy, inhibin B was invariably undetectable. In patients with bilateral spermatocytic arrest, inhibin B remained within the normal range, which is consistent with a role of spermatocytes in the maintenance of inhibin B secretion. Our data support the view that, in contrast to recently published data, in patients with AZF microdeletions the serum concentration of inhibin B is dependent upon the functional interaction between Sertoli cells and spermatocytes and/or spermatids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466362     DOI: 10.1210/jc.2002-020737

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  CUA Guideline: The workup of azoospermic males.

Authors:  Keith Jarvi; Kirk Lo; Anthony Fischer; John Grantmyre; Armand Zini; Victor Chow; Victor Mak
Journal:  Can Urol Assoc J       Date:  2010-06       Impact factor: 1.862

2.  Increased apoptosis of germ cells in patients with AZFc deletions.

Authors:  Kyoko Yamada; Kazuyuki Fujita; Jinhua Quan; Masayuki Sekine; Katsunori Kashima; Tetsuro Yahata; Kenichi Tanaka
Journal:  J Assist Reprod Genet       Date:  2010-03-24       Impact factor: 3.412

Review 3.  The Y chromosome-linked copy number variations and male fertility.

Authors:  C Krausz; C Chianese; C Giachini; E Guarducci; I Laface; G Forti
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

4.  Predictive significance of serum inhibin B on testicular haploid gamete retrieval outcomes in nonobstructive azoospermic men.

Authors:  Zhi-Guo Zhu; Zhi-Gang Zhao; Qing-Yang Pang; Tong Chen; Jian-Min Zhang; Tai-Jian Zhang; Chao Xu; Hao-Bo Zhang; Wen Liu; Xu-Jun Xuan
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

5.  Clinical application value of Inhibin B alone or in combination with other hormone indicators in subfertile men with different spermatogenesis status: A study of 324 Chinese men.

Authors:  Xiangbin Kong; Zhen Ye; Yaoping Chen; Huan Zhao; Jian Tu; Tianqing Meng; Chengliang Xiong; Honggang Li; Yijun Gong; Liang Zheng; Bangning Cheng; Zhijun Zhang; Peng Xu
Journal:  J Clin Lab Anal       Date:  2021-06-28       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.